Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Pharmala Biotech Holdings Inc C.MDMA

Alternate Symbol(s):  MDXXF

PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the development, manufacture and sales of methylenedioxy methamphetamine (MDMA) and methylenedioxy phenethylamines (MDXX) class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The Company has three primary business lines... see more

Bullboard (CSE:MDMA)

View:
Post by inviolablspiriton Mar 14, 2024 1:58pm

Horizens Psychedelics ETF is closing this month

The reasons for the downward pressure on MDMA, NUMI and others in the sector is that the Horizens Psych. ETF is closing at the end of this month.  I think the last time I looked at the portfolio ...more  
Comment by polygraph46on Mar 12, 2024 3:45pm

RE:Sold I must say this is not going to go anywhere

moneywhine....your quote "garbage people running this company".  Attention span?  And I know you can't back up that inane comment.  Do some research......pg
Post by moneywinner1on Mar 12, 2024 9:40am

Sold I must say this is not going to go anywhere

No respect to CEO and the board of garbage people running this company. Shares slide like garbage companies do . Stay away . Sold with loss of 6% 
Comment by Firepokeron Mar 11, 2024 4:40pm

RE:Could not refuse

Same  this might be the last opportunity to load up on the sp this low ....back up the truck.
Post by moneywinner1on Mar 11, 2024 2:45pm

Could not refuse

Filled 17.5 as starting point, let's see what next . Up to the moon 
Comment by moneywinner1on Mar 10, 2024 10:56pm

RE:RE:MDMA larger piece of TRIP pie???

Agree but market makers must see value over 0.30 before anything is happening 
Comment by Firepokeron Mar 09, 2024 7:50am

RE:MDMA larger piece of TRIP pie???

 my conclusions from his answers to questions at the AMA regarding TRIP... Nick was approached by TRIP for assistance  because of Nick''s and Pharmala highly regarded reputation ...more  
Comment by Firepokeron Mar 09, 2024 7:14am

RE:I pass on this one

You do not see the upside to working with TRIP??? Or ??
Post by moneywinner1on Mar 08, 2024 2:13pm

I pass on this one

I just do not see upside 
Post by moneywinner1on Mar 08, 2024 10:23am

Wow you guys having story to tell

What is going on? Anyone with information , please post . Might be the time to buy if news next week??? 
Post by Firepokeron Mar 08, 2024 9:02am

MDMA larger piece of TRIP pie???

"We are excited to partner with PharmAla as our GMP consultants and potentially as our exclusive sales agents once those products are fully developed." This was a snippet from the previous ...more  
Post by Firepokeron Mar 05, 2024 12:31am

AMA with Ceo of MDMA

Nick (Ceo of MDMA) came on CEO board to state, he will be doing an AMA on Fri 5pm...if you have questions email to him.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities